Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.08B | 4.42B | 4.41B | 5.25B | 5.81B | Gross Profit |
1.25B | 1.82B | 1.73B | 1.64B | 1.56B | EBIT |
0.00 | 0.00 | -3.27B | -3.05B | -6.01B | EBITDA |
-2.82B | -2.82B | -2.88B | -2.55B | -5.38B | Net Income Common Stockholders |
-3.42B | -3.40B | -3.41B | -3.10B | -6.02B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
24.88B | 24.11B | 24.83B | 23.78B | 26.09B | Total Assets |
46.23B | 45.58B | 46.44B | 44.18B | 45.07B | Total Debt |
15.27B | 12.77B | 9.59B | 4.79B | 1.05B | Net Debt |
1.03B | 330.67M | -8.35B | -11.79B | -15.33B | Total Liabilities |
24.80B | 22.78B | 20.88B | 16.96B | 15.11B | Stockholders Equity |
21.43B | 22.81B | 25.56B | 27.22B | 29.89B |
Cash Flow | Free Cash Flow | |||
-2.60B | -4.19B | -3.82B | -4.60B | -7.72B | Operating Cash Flow |
-2.54B | -4.05B | -3.74B | -4.50B | -7.48B | Investing Cash Flow |
752.57M | -4.89B | -844.08M | 1.54B | -4.48B | Financing Cash Flow |
2.53B | 3.29B | 4.96B | 3.83B | 801.28M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | €46.94B | 4.32 | 6.52% | 9.46% | 0.74% | -33.05% | |
70 Outperform | €141.51B | 14.80 | 14.18% | 2.67% | -1.13% | 8.98% | |
66 Neutral | €281.45B | 49.13 | 7.05% | 0.91% | 10.51% | 203.37% | |
62 Neutral | $33.52B | 35.96 | 8.74% | 1.23% | -8.61% | -68.53% | |
59 Neutral | $10.59B | 10.09 | -6.37% | 3.05% | 7.44% | -10.67% | |
56 Neutral | €22.08B | ― | -7.87% | 0.50% | -2.16% | 13.22% | |
40 Underperform | $807.96M | ― | -15.25% | ― | -32.33% | 2.35% |